hypoglycemia glp-1 Drugs and Type 1 Diabetes: Less Insulin, Better Time in Range — What the Evidence In type 1 patients with

The field currently lacks the application of standardized approaches for microbiota modulation, like FMT and precision nutrition, which further hinder reproducibility and clinical application (Lu et al., 2024)

Yes, a prescription or referral is generally required

Credit/Source: The legendary Maryam Daneshpour #biotech #pharma #biopharma #CDMO To view or add a comment, sign in Expansions, investments & partnerships: CDMOs continue to strengthen their global footprint

Current GLP-1 medications include: Wegovy (semaglutide) licensed for weight loss Ozempic and Rybelsus (semaglutide) licensed for type 2 diabetes Mounjaro (tirzepatide) licensed for both diabetes and weight loss Liraglutide varies by brand

Abrar Qureshi